GetTopicDetailResponse(id=944d11829455, topicName=腫瘤個(gè)性化治療, introduction=, content=腫瘤個(gè)性化治療 mRNA-4157, image=null, comments=0, allHits=504, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Sun Aug 25 00:51:21 CST 2024, time=2024-08-25, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=476263, tagList=[TagDto(tagId=476263, tagName=腫瘤個(gè)性化治療)], ipAttribution=上海, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2222292, encodeId=61a0222229221, content=<a href='/topic/show?id=944d11829455' target=_blank style='color:#2F92EE;'>#腫瘤個(gè)性化治療#</a> <a href='/topic/show?id=e79f1091e1bd' target=_blank style='color:#2F92EE;'>#mRNA-4157#</a>, objectTitle=聽(tīng)起來(lái)像是科幻，個(gè)性化癌癥治療在 I 期臨床試驗(yàn)中顯示出安全性和持續(xù)的免疫反應(yīng)！, objectType=article, longId=839958, objectId=7a1c8399587b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240718/1721284524390_8538692.jpg, objectUrl=/article/show_article.do?id=7a1c8399587b, replyNumber=0, likeNumber=89, createdTime=2024-08-25, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=7a1c8399587b, moduleTitle=聽(tīng)起來(lái)像是科幻，個(gè)性化癌癥治療在 I 期臨床試驗(yàn)中顯示出安全性和持續(xù)的免疫反應(yīng)！, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=7a1c8399587b)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2024-08-25發(fā)表于上海
